Gabriella E. Bensur
Gabriella E. Bensur is a litigation associate in White & Case's New York office and a member of the Global Antitrust/Competition Group. Her practice focuses on complex litigation in the areas of antitrust and other commercial disputes, representing clients in the pharmaceutical, technology, food and beverage, and insurance industries. Gabriella has represented several leading global pharmaceutical companies in class action litigation matters at the cutting edge of antitrust and intellectual property.
Gabriella has also been active in a variety of pro bono matters, with a particular interest in representing victims of domestic abuse in family court proceedings. She additionally has represented low-income individuals in employment and civil rights litigations in both state and federal court.
During law school, Gabriella served as a Notes Editor on the Cornell Law Review and as a member of the Moot Court Board. Gabriella also completed a federal clerkship in the Middle District of Pennsylvania.
Representing Gilead in a class action lawsuit relating to Gilead's HIV product portfolio, where plaintiffs allege that innovative joint ventures, lawful settlements with generics, and the procompetitive development of life-saving products were actually unlawful. The team is vigorously defending Gilead's history of innovative collaboration and competition in HIV medicines. The case is set for trial in August 2022.
Representation of Allergan/Warner Chilcott in a reversal of class certification by the First Circuit US Court of Appeals. The ruling bans the widespread use of aggregate proof and post-trial affidavits as a substitute for fact-finding by juries under the Seventh Amendment of the US Constitution and Rule 23.
Successful representation of Allergan in nationwide antitrust class action litigation regarding the company's leading Botox® Cosmetic product. The plaintiffs sought to prevent competition by blocking an exclusive license agreement that would create new competition in the sale of injectable neurotoxins in the United States.
Served as a member of a team that handles all international litigation for Facebook, including matters implicating international data protection, privacy, defamation, hosting provider liability, intellectual property and censorship laws, with focus on German litigation matters.
Representation of pharmaceutical company Boehringer Ingelheim against allegations of an anticompetitive "reverse payment" patent settlement relating to the blockbuster drug Aggrenox®.
Successful pursuit of damages for Chinese juice manufacturer based on breach of contract and fraud.
Counseling to Kenyan company for compliance with Foreign Corrupt Practices Act.